NMR study of spin dynamics in disordered Heisenberg paramagnets

The spin dynamics in the disordered paramagnets KMg_1?xMn_xF₃ and Zn_1?xMn_xF₂ were investigated using the F¹⁹ NMR. Linewidths and relaxation rates of those distinct classes of F¹⁹ nuclei that have different numbers of nearest neighbor magnetic ions were obtained as a function of concentration x. The particular importance of the isolated magnetic ion to the low frequency spectral density was established.     

Synthesis of 3-substituted-2,3,4,5-tetrahydro-1H-naphth[1,2-d]-imidazole-2,4,5-triones and 1-Substituted-2,3,4,9-tetrahydro-1H-naphth[2,3-d]imidazole-2,4,9-triones

Tricyclic compounds with an imidazolinone ring fused to 1,2- and 1,4-naphtoquinones were synthesized by a reaction of 4-amino-1,2-naphthoquinone and 2-amino-1,4-naphthoquinone with electrophilic symmetric and non symmetric diazenes.     

14N NMR study of (CH3)4 NMnCl3 (TMMC)

The ¹⁴N chemical shift and quadrupole coupling constant in TMMC has been determined as a function of temperature from NMR measurements. The results are discussed in terms of the crystal structure and of the phase transition.     

Synthesis of some 3,7-disubstituted quino[3,2-c][1,8]naphthyridines

The preparation of some 3,7-disubstituted-5,6-dihydroquino[3,2-c][1,8]naphthyridines ( 6 ) by the condensation of 7-substituted-2,3-dihydro-1,8-naphthyridin-4-(1H)ones ( 5 ) with o-aminoacetophenone or o-aminobenzophenone is described. All the 5,6-dihydroderivatives 6 were transformed into the fully aromatic compounds 7 by heating with nitrobenzene. Only a few quino[3,2-c][1,8]naphthyridines were previously described.     

A New Kid on the Block: Sacituzumab Govitecan for the Treatment of Breast Cancer and Other Solid Tumors

Human trophoblast cell-surface antigen-2 (Trop-2) is a membrane glycoprotein involved in cell proliferation and motility, frequently overexpressed in epithelial tumors. Thus, it represents an attractive target for anticancer therapies. Sacituzumab govitecan (SG) is a third-generation antibody-drug conjugate, consisting of an anti-Trop-2 monoclonal antibody (hRS7), a hydrolyzable linker, and a cytotoxin (SN38), which inhibits topoisomerase 1. Specific pharmacological features, such as the high antibody to payload ratio, the ultra-toxic nature of SN38, and the capacity to kill surrounding tumor cells (the bystander effect), make SG a very promising drug for cancer treatment. Indeed, unprecedented results have been observed with SG in patients with heavily pretreated advanced triple-negative breast cancer and urothelial carcinomas, and the drug has already received approval for these indications. These results are coupled with a manageable toxicity profile, with neutropenia and diarrhea as the most frequent adverse events, mainly of grades 1–2. While several trials are exploring SG activity in different tumor types and settings, potential biomarkers of response are under investigation. Among these, Trop-2 overexpression and the presence of BRCA1/2 mutations seem to be the most promising. We review the available literature concerning SG, with a focus on its toxicity spectrum and possible biomarkers of its response.     

Reactions of Co2(CO)8 and of Co2(CO)6L (L = 3-pentyn-1-ol, 1,4-butyn-diol or 2-methyl-3-butyn-2-ol) with 2(diphenylphosphino)ethyl-trietoxysilane and tris(hydroxymethyl)phosphine for applications to new sol-gel materials

The complex Co₂(CO)₆[μ-η²-(H₃CCCCH₂CH₂OH)] (1) with the ligand 3-pentyn-1-ol (pol) has been synthesized following established procedures. Its structure has been determined by X-ray analysis. The complex Co₂(CO)₆(mbo) (mbo = 2-methyl-3-butyn-2-ol, HCCC(CH₃)₂OH), (3), along with the already known Co₂(CO)₆(bud) (bud = 1,4-butyn-diol, HOCH₂CCCH₂OH) (2), and Co₂(CO)₈ were reacted with 2(diphenylphosphino)ethyl-triethoxysilane [Ph₂PCH₂CH₂Si(OCH₂CH₃)₃] (dpts) and tris(hydroxymethyl)phosphine [P(CH₂OH)₃] (thp). With dpts, mono- and di-substituted complexes were obtained: these were characterized by analytical and spectroscopic techniques. The structures of Co₂(CO)₆(dpts)₂ (5) and of Co₂(CO)₄(pol)(dpts)₂ (8) have been determined by X-ray analysis.Complex (1) was reacted with 3-(triethoxysilyl)propyl isocyanate [(H₃CCH₂O)₃Si(CH₂)₃NCO] (tsi): the new complex Co₂(CO)₆[H₃CCCCH₂CH₂OC(O)NH(CH₂)₃Si(OCH₂CH₃)₃] (9) was obtained and spectroscopically characterized. The complex has also been reacted with tetraethyl orthosilicate (teos); a new inorganic-organometallic material was obtained. Complex (5) has been grafted on the mesoporous material SBA-15. The hybrid inorganic-organometallic materials obtained have been characterized by inductively coupled plasma-mass spectrometry (ICP-MS), infrared spectroscopy (FT-IR) under vacuum conditions, X-ray diffraction (XRD) and scanning electron microscopy coupled to EDS probe (SEM-EDS).